Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01196442 · ClinicalTrials.gov registry record · NA

Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer

A NA study of Pain and Peripheral Neuropathy, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
39
Enrollment target
1
Study location

NCT01196442: Completed NA study of Pain and Peripheral Neuropathy, sponsored by Virginia Commonwealth University.

NCT01196442 is a NA study of Pain and Peripheral Neuropathy that has completed, run by Virginia Commonwealth University. The registered enrollment target is 39 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01196442, a NA study of Pain and Peripheral Neuropathy, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Electrical stimulation pain therapy may help relieve chronic pain and numbness caused by chemotherapy. PURPOSE: This pilot trial studies electrical stimulation pain therapy in treating chronic pain and numbness caused by chemotherapy in patients with cancer.

Primary Outcome

Change in Brief Pain Inventory (Now)Scale 1 (none) to 5 (complete interference)

Interventions

  • OTHER questionnaire administration
  • OTHER electrical stimulation pain therapy

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2010-09
Est. Completion 2013-01
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT01196442 record still lists

NCT01196442 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (87% lower).

The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which questionnaire administration is the first listed.

NCT01196442 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT01196442 about?

NCT01196442 is a clinical study titled "Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer". RATIONALE: Electrical stimulation pain therapy may help relieve chronic pain and numbness caused by chemotherapy. PURPOSE: This pilot trial studies electrical stimulation pain therapy in treating chronic pain and numbness caused by chemotherapy in patients with cancer.

What is the current status of trial NCT01196442?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2010-09. Estimated completion is 2013-01.

What conditions does trial NCT01196442 study?

This clinical trial studies the following conditions: Pain, Peripheral Neuropathy, Neurotoxicity, Cancer-related Problem/Condition.

What interventions are being tested in trial NCT01196442?

The interventions under investigation include: questionnaire administration (OTHER), electrical stimulation pain therapy (OTHER).

Who is sponsoring clinical trial NCT01196442?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01196442 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01196442's enrollment target sits among peer trials

39 291st of 374 higher than 83 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465592 · 39 participants · Phase 1

    Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

  • NCT03961776 · 39 participants

    Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems

  • NCT04050280 · 39 participants · Phase 2

    CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

  • NCT04190862 · 39 participants · Phase 1

    E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01196442, the US trial registry maintained by the National Library of Medicine. NCT01196442 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.